DAKAR (Reuters) -Malian tax officials have reopened Barrick Mining's office in the capital under a court-appointed ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways ...

With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways ...

Wednesday marked a losing session on Wall Street, with the S&P 500 snapping its three-day win streak, as did the Nasdaq ...

Partnership aims to develop first-in-class, small molecule therapeutics directed at a novel non-incretin GPCR target for ...

PR Newswire LAS VEGAS, June 10, 2025 The growth hormone deficiency market is expected to see expansion across the 7MM driven by the introduction of innovative therapies, including ...

The LEO satellite market is projected to grow from USD 11.81 billion in 2025 to USD 20.69 billion by 2030, registering a CAGR ...

Novo Nordisk (NVO-0.32%) has enjoyed tremendous success with semaglutide, the proprietary drug in Ozempic and Wegovy. However, competition is picking up with multiple next-generation drugs working ...

Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight loss market. As Reuters reports today, an online weight loss company ...